High Dose Valaciclovir As CMV Prophylaxis in Allogeneic Hematopoietic Stem Cell Recipients at High Risk of CMV Reactivation

被引：0
|
作者：
Douglas, Genevieve
Yong, Michelle K.
Tio, Shio Yen
Chau, Maggie
Sasadeusz, Joe
Slavin, Monica
Xie, Mingdi
Ritchie, David
Chee, Lynette C. Y.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141764
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Application of CMV-IVIg as prophylaxis against cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation patients
    Cui, Jiaqi
    Zhou, Yuhang
    Zhao, Kui
    Li, Xudong
    Zhang, Hanyue
    Zhang, Xiangzhong
    Sun, Yanling
    Long, Bing
    CLINICAL TRANSPLANTATION, 2024, 38 (04)
  • [22] Letermovir for CMV Prophylaxis in Very High-Risk Pediatric Hematopoietic Stem Cell Transplantation Recipients for Inborn Errors of Immunity
    Cesar, Thibaut
    Le, Minh P.
    Klifa, Roman
    Castelle, Martin
    Fournier, Benjamin
    Levy, Romain
    Chbihi, Marwa
    Courteille, Virginie
    Moshous, Despina
    Blanche, Stephane
    Alligon, Mickael
    Leruez-Ville, Marianne
    Peytavin, Gilles
    Frange, Pierre
    Neven, Benedicte
    JOURNAL OF CLINICAL IMMUNOLOGY, 2024, 44 (01)
  • [23] Impact of high-dose oral acyclovir prophylaxis on cytomegalovirus (CMV) disease in CMV high-risk renal transplant recipients
    Kletzmayr, J
    Kotzmann, H
    PopowKraupp, T
    Kovarik, J
    Klauser, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (02): : 325 - 330
  • [24] Efficacy and Pharmacoeconomic Impact of Letermovir for CMV Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients
    Merchant, Shelby Lorraine
    Gatwood, Katie S.
    Satyanarayana, Gowri
    Byrne, Michael T.
    Kassim, Adetola A.
    Jagasia, Madan
    Savani, Bipin
    Engelhardt, Brian G.
    Culos, Kathryn Ann A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [25] How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation
    Einsele, Hermann
    Ljungman, Per
    Boeckh, Michael
    BLOOD, 2020, 135 (19) : 1619 - 1629
  • [26] CMV reactivation in pediatric hematopoietic stem cell transplantation
    Yoon, Hoi Soo
    Seo, Jong Jin
    Choi, Eun Seok
    Song, Joon Sup
    Im, Ho Joon
    Moon, Hyung Nam
    Park, Chan Jeoung
    Chi, Hyun Sool
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 502 - 502
  • [27] Cmv Specific Cellmediated Immune Reconstitution During Letermovir Prophylaxis in High Risk Hematopoietic Cell Transplant Recipients
    Abidi, M.
    Gutman, J.
    Weinberg, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 408 - 408
  • [28] Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus
    Lee, C.
    Rahman, S.
    Baranowska, J.
    Moeller, C. M.
    Valledor, A. Fernandez
    Rubenstein, G.
    Oren, D.
    Oh, K.
    Bae, D.
    Raikhelkar, J.
    Lotan, D.
    DeFilippis, E. M.
    Theodoropoulos, K.
    Fried, J.
    Clerkin, K.
    Latif, F.
    Topkara, V.
    Yuzefpolskaya, M.
    Colombo, P.
    Lin, E.
    Majure, D.
    Sayer, G.
    Uriel, N.
    Choe, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S519 - S519
  • [29] Risk Factors for Progression of CMV Viremia to CMV Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Mack, Johnathan P.
    Tan, Xianming
    Vinh, Donald C.
    Popradi, Gizelle
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S296 - S297
  • [30] Impact of extended CMV prophylaxis in adult renal transplant recipients at high risk for CMV infection
    Stuckey, Linda J.
    Park, Jeong M.
    Luan, Fu L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 565 - 565
12345